This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Georgetown University. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2012
Title: Thierry Hauet: Innovator in Organ Health Assessment
Introduction
Thierry Hauet is a notable inventor based in Saint Benoit, France. He has made significant contributions to the field of organ health assessment, particularly in the context of transplantation therapy. With a total of 3 patents, his work focuses on innovative methods for evaluating organ damage and regeneration.
Latest Patents
Hauet's latest patents include groundbreaking inventions that utilize the expression level of peripheral-type benzodiazepine receptor (PBR) as an index of organ health. One of his patents details methods, reagents, and kits for assessing organ damage, specifically damage due to ischemia reperfusion injury. This invention provides a method for determining an index of organ health during transplantation therapy by measuring PBR expression levels. Additionally, it offers a way to assess the progress of organ regeneration by comparing the index of organ health, making it a valuable tool for predicting the outcomes of transplantation therapy.
Career Highlights
Throughout his career, Thierry Hauet has worked with esteemed institutions such as Georgetown University and Macopharma. His expertise in organ health assessment has positioned him as a key figure in the field, contributing to advancements that benefit transplantation practices.
Collaborations
Hauet has collaborated with notable professionals, including Vassilios Papadopoulos and François Barrou. These partnerships have further enriched his research and innovations in organ health.
Conclusion
Thierry Hauet's contributions to the field of organ health assessment through his innovative patents demonstrate his commitment to improving transplantation outcomes. His work continues to influence the medical community and enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
